Inventor · disambiguated record
Andreas Sommer
Also filed as: SOMMER ANDREAS
23 granted patents·14 pending applications·570 citations·filing 1989–2024
97Inventor score
Top patents by PatentIndex Score
37 records- 0196US10166183B2Pharmaceutical formulationsAUSPEX PHARMACEUTICALS INC·Filed 2015·Granted Jan 1, 2019·22 cites·21 claims
- 0294US9296739B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2014·Granted Mar 29, 2016·21 cites·27 claims
- 0394US9233959B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2014·Granted Jan 12, 2016·22 cites·27 claims
- 0490US9814708B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2016·Granted Nov 14, 2017·6 cites·39 claims
- 0590US9346800B2Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2013·Granted May 24, 2016·9 cites·20 claims
- 0690US6599873B1Interleukin-1 inhibitors, compositions, and methods of treatmentAMGEN INC·Filed 1995·Granted Jul 29, 2003·97 cites·296 claims
- 0789US2024366591A1Formulations and Pharmacokinetics of Deuterated Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0887US4994559AHuman basic fibroblast growth factorSYNERGEN INC·Filed 1989·Granted Feb 19, 1991·83 cites·1 claims
- 0987US2025179064A1Benzoquinolone inhibitors of vmat2AUSPEX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1082US9550780B2Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2016·Granted Jan 24, 2017·4 cites·27 claims
- 1182US2023355514A1Pharmaceutical formulationsAUSPEX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1281US11033540B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2019·Granted Jun 15, 2021·0 cites·38 claims
- 1378US6040292AMethods for treating diabetesCELTRIX PHARMA·Filed 1999·Granted Mar 21, 2000·43 cites·14 claims
- 1478US5332804AHigh molecular weight human angiogenic basic fibroblast growth factorsSYNERGEN INC·Filed 1991·Granted Jul 26, 1994·36 cites·5 claims
- 1577US2021244723A1Formulations and Pharmacokinetics of Deuterated Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1676US10966922B2Pharmaceutical formulationsAUSPEX PHARMACEUTICALS INC·Filed 2019·Granted Apr 6, 2021·0 cites·16 claims
- 1775US5407913AMethod and composition for systemic treatment of tissue injuryCELTRIX PHARMA·Filed 1992·Granted Apr 18, 1995·50 cites·28 claims
- 1874US2021205214A1Novel pharmaceutical formulationsAUSPEX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1973US11666566B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2020·Granted Jun 6, 2023·0 cites·18 claims
- 2073US2021355120A1Benzoquinolone inhibitors of vmat2AUSPEX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2173US2021322308A1Novel pharmaceutical formulationsAUSPEX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2272US2019133935A1Novel pharmaceutical formulationsAUSPEX PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2370US5070159AAddition compounds, a process for the preparation, and their use, based on epoxy novolac-fatty amine adductsHOECHST AG·Filed 1989·Granted Dec 3, 1991·11 cites·15 claims
- 2470US2020165240A1Benzoquinolone inhibitors of vmat2AUSPEX PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2569US2019083484A1Formulations And Pharmacokinetics Of Deuterated Benzoquinoline Inhibitors Of Vesicular Monoamine Transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2668US6858409B1Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitorsAMGEN INC·Filed 1995·Granted Feb 22, 2005·35 cites·105 claims
- 2766US5026839ADNA encoding a basic fibroblast growth factorSYNERGEN INC·Filed 1990·Granted Jun 25, 1991·37 cites·1 claims
- 2863US2017087147A1Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2962US5112404APigment formulations, processes for their preparation and their useHOECHST AG·Filed 1990·Granted May 12, 1992·22 cites·12 claims
- 3062US2016068526A1Benzoquinolone inhibitors of vmat2AUSPEX PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3161US6124259AMethod for treating ophthalmic disorders with IGFBPCELTRIX PHARMA·Filed 1998·Granted Sep 26, 2000·29 cites·14 claims
- 3261US2018208592A1Benzoquinolone inhibitors of vmat2AUSPEX PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 3356US5643867AMethod for treating catabolic conditionsCELTRIX PHARMA·Filed 1995·Granted Jul 1, 1997·19 cites·22 claims
- 3451US5188943AMethod of producing high molecular weight human fibroblast growth factorsSYNERGEN INC·Filed 1991·Granted Feb 23, 1993·10 cites·1 claims
- 3546US5789547AMethod of producing insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) with correct folding and disulfide bondingCELTRIX PHARMA·Filed 1995·Granted Aug 4, 1998·6 cites·34 claims
- 3643US5948757AHigh dose IGF-1 therapyCELTRIX PHARMA·Filed 1996·Granted Sep 7, 1999·8 cites·2 claims
- 3738US2011206661A1Trimethoxyphenyl inhibitors of tyrosine kinaseAUSPEX PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andreas Sommer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →